Solstice Oncology, Inc. · CIK 2116600
Solstice Oncology, Inc.
Filings
1
Original notices
1
Amendments
0
Activity
Mar 9, 2026
through Mar 9, 2026
through Mar 9, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot
- Reported offering amount
- $298,400,851
- Reported exemptions
- Rule 506(b)
- Reported amount sold
- $121,260,306
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Related person name and locality match
Matches in stored disclosures are research leads. They do not establish common ownership or confirm identity.
- Imbria Pharmaceuticals, Inc. · CIK 1745672
- Lonestar Medicines, Inc. · CIK 2111460
- Pahr Therapeutics, Inc. · CIK 2077159
- Slate Medicines, Inc. · CIK 2117806
- Superluminal Medicines, Inc. · CIK 1989478
Form D filings (1)
-
0002116600-26-000002D · Mar 9, 2026 · BiotechnologyOffering: $298,400,851Sold: $121,260,306